Performance of KRAS mutation detection in plasma exosomes from patients with early-stage colorectal cancer
Abstract Background Liquid biopsy is a minimally invasive method, which is an alternative to tissue biopsy in solid cancers to detect driver mutations, monitor treatment responses, and estimate prognosis. Exosomes are a group of extracellular vesicles that are detected in body fluids and are more st...
Saved in:
| Main Authors: | Mehraneh Nouri, Samaneh Sharif, Ehsan Soltani, Sina Mozaffari-Jovin, Mohammad Reza Abbaszadegan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06710-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting the HER2-ELF3-KRAS axis: a novel therapeutic strategy for KRASG13D colorectal cancer
by: Soo-Yeon Hwang, et al.
Published: (2025-05-01) -
Research progress on predicting KRAS gene mutations in colorectal cancer by combining radiomics and multimodal medical imaging
by: Min Ai, et al.
Published: (2025-08-01) -
Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth
by: Yu Zhou, et al.
Published: (2019-12-01) -
Analysis of Colorectal Cancer Gene Mutations and Application of Long Blocker Displacement Amplification Technology for High-Throughput Mutation Detection
by: Ping Lu, et al.
Published: (2025-05-01) -
Computational screening of phytochemicals targeting mutant KRAS in colorectal cancer
by: Muskan Arooj, et al.
Published: (2025-08-01)